Wits University in collaboration with Oxford University are focusing on developing a vaccine that will also be safe to use for people living with HIV.
Professor Sabhir Madhi is the principal investigator in the study being led by South African scientists with assistance from Oxford University. The trial is being funded by the South African Medical Research Council and the Bill and Melinda Gates Foundation.Madhi said the first phase has started in the United Kingdom with 7,000 participants, with 2000 people in the second phase in SA and the third phase being in Brazil. The trial will also be taken to other countries such as the United States.
We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more: